Inventor
DARRYL KATO
Inventor
US
Overview
Patents· 12 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07DHeterocyclic compounds25%
C07CAcyclic or carbocyclic compounds8%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium8%
C07KPeptides4%
Y02ATechnologies for adaptation to climate change4%
PatentTitleYear
12,479,853HIV inhibitor compounds202512,448,400KRAS G12D modulating compounds202512,404,262Therapeutic compounds for HIV virus infection202512,202,842MCL1 inhibitors202512,187,753Therapeutics compounds for HIV virus infection202512,162,844MCL-1 inhibitors202412,084,467Therapeutic compounds for HIV virus infection202412,084,455HIV inhibitor compounds202411,787,825Therapeutic compounds for HIV virus infection202311,680,064Capsid inhibitors for the treatment of HIV202311,667,652MCL1 inhibitors202311,643,400MCL-1 inhibitors2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to GILEAD SCIENCES INC (12)· patent assignee history
2023–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GILEAD SCIENCES INC | 12 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 12 | 2023–2025 |